IRVINE, Calif., May 13 /PRNewswire-FirstCall/ -- Endocare, Inc. , an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation, today announced that it is scheduled to make an investor presentation at the Seventh Annual JMP Securities Research Conference at 12:30 p.m. PT (3:30 p.m. ET) on Tuesday, May 20, 2008. The conference is being held at the Ritz-Carlton, San Francisco May 19-21.
A live webcast of the Company's presentation at the conference will be available via a link provided at http://ir.endocare.com/events.cfm. An archived replay of the presentation will be available shortly after the presentation time for a period of 90 days. Web participants are encouraged to go to the Company's website (http://ir.endocare.com/events.cfm).
About Endocare
Endocare, Inc. -- http://www.endocare.com -- is an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation. Endocare has initially concentrated on developing cryoablation (freezing) technologies for the treatment of prostate cancer and believes that its proprietary technologies have broad applications across a number of markets, including the ablation of tumors in the kidney, lung and liver and palliative intervention (treatment of pain associated with metastases).
CONTACT: Investors, Matt Clawson, matt@allencaron.com, or Media, Len Hall,
len@allencaron.com, both of Allen & Caron, Inc., +1-949-474-4300, or for
additional information, Craig T. Davenport, CEO, or Michael R. Rodriguez,
CFO, both of Endocare, Inc., +1-949-450-5400
Web site: http://www.endocare.com/
